Sumary of Statins May Reduce the Risk of COVID-19 Death by 41 Percent: Here's Why:
- Marko Geber/Getty ImagesResearchers report that statins appear to significantly lower the risk of death from COVID-19.They say the cholesterol-lowering drugs may do this by reducing inflammation and lowering blood pressure.
- Scientists continue to explore the potential harms of COVID-19 to the body and study ways to prevent people from getting seriously ill or dying from the disease.
- In a new study from the University of California San Diego School of Medicine, researchers reported that people taking statin medications had a 41 percent lower risk of in-hospital death from COVID-19.Statins are widely prescribed drugs commonly used to reduce blood cholesterol levels by blocking liver enzymes responsible for making cholesterol.
- The new findings expand on previous research conducted at UC San Diego Health in 2020.Dr. Lori Daniels, the lead author of the study, is a professor and director of the Cardiovascular Intensive Care Unit at UCSD Health.
- Researchers said there are several reasons statins may help reduce COVID-19’s severity.
- Among them are that statins can reduce inflammation, lower blood pressure, and help stabilize other underlying conditions that can raise the risk of serious illness from COVID-19.She explained that the initial study included 170 anonymized medical records from people receiving care at UC San Diego Health.
- In these people, researchers reported that statin use before hospital admission for COVID-19 resulted in a more than 50 percent reduction in risk of developing severe infection.
- Researchers analyzed anonymized medical records of 10,541 people admitted for COVID-19 from January through September 2020 at 104 U.S. hospitals.